Prognostic Significance of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Esophageal and Gastric Cancer

被引：0
|
作者：
Chan, David S.
Reid, Tom D.
Blackshaw, Guy
Crosby, Tom
Lewis, Wyn G.
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S528 / S528
页数：1
相关论文
共 50 条
  • [21] Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
    Park, Ji Soo
    Rha, Sun Young
    Chung, Hyun Cheol
    Jung, Minkyu
    Kim, Ki Hyang
    Jun, Hyun Jung
    Kim, Hyunki
    An, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    ONCOLOGY, 2015, 88 (03) : 147 - 156
  • [22] Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
    Siena, S.
    Sartore-Bianchi, A.
    Marsoni, S.
    Hurwitz, H. I.
    McCall, S. J.
    Penault-Llorca, F.
    Srock, S.
    Bardelli, A.
    Trusolino, L.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1108 - 1119
  • [23] Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing
    Chung, H.
    Bang, Y. J.
    Xu, J. M.
    Lordick, F.
    Sawaki, A.
    Lipatov, O.
    Lehle, M.
    Pickl, M.
    Rueschoff, J.
    Van Cutsem, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 364 - 364
  • [24] Prognostics significance of epidermal growth factor receptor and HER2 overexpression in prostate cancer.
    Schlomm, Thorsten
    Erbersdobler, Andreas
    Luebke, Andreas M.
    Graefen, Markus
    Huland, Hartwig
    Sauter, Guido
    Simon, Ronald
    CANCER RESEARCH, 2006, 66 (08)
  • [25] Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: Quantitative analysis of HER2 overexpression effects
    Hendriks, BS
    Opresko, LK
    Wiley, HS
    Lauffenburger, D
    CANCER RESEARCH, 2003, 63 (05) : 1130 - 1137
  • [26] Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma
    Hyeongbin Kim
    SangHyuk Seo
    KwangHee Kim
    Yo-Han Park
    MinSung An
    HyungJoo Baik
    ChangSoo Choi
    SangHoon Oh
    World Journal of Surgical Oncology, 17
  • [27] Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma
    Kim, Hyeongbin
    Seo, SangHyuk
    Kim, Kwanghee
    Park, Yo-Han
    An, MinSung
    Baik, HyungJoo
    Choi, ChangSoo
    Oh, SangHoon
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (01)
  • [28] HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) POSITIVITY IN SPANISH PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER (GC)
    Alejandro, M. Alvarez
    Pazo Cid, R. A.
    Yus, C.
    Remon, L.
    Madani, J.
    Cebollero De Miguel, A.
    Gil, I.
    Lao Romera, J.
    Lecumberri Biurrum, M. J.
    Anton, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
  • [29] The landscape of human epidermal growth factor receptor 2 (HER2) expression in gynecologic tumors (GTs)
    Duran, C. Garcia
    Musacchio, L.
    Mazzeo, R.
    Carita, L.
    Jimenez, J.
    Bejar, J. F. Grau
    Illescas, D. G.
    Fasani, R.
    Madrid, L. Farinas
    Villacampa, G.
    Oaknin, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S590 - S591
  • [30] The Prognostic Significance of Human Epidermal Growth Factor Receptor-2 (HER2) Positivity and Breast Cancer Subtype in Patients (PTS) with Microinvasive Breast Cancer (MIBC)
    Margalit, D. N.
    Brock, J. E.
    Sreedhara, M.
    Chen, Y.
    Catalano, P. J.
    Nguyen, P. L.
    Harris, J. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S227 - S227
12345